**Never shake.** Shaking denatures peptide bonds and can reduce potency
Preclinical models report accelerated structural restoration following peptide exposure, characterized by increased fibroblast proliferation, enhanced extracellular matrix organization, and improved collagen deposition
Regulatory reality: Tesamorelins approved-drug status (EGRIFTA) brings a real prescribing label with IGF-1 and glucose monitoring requirements and clear contraindications which is why those safety rules carry over to the research framing here
This medication is best for people with obesity and overweight who want to reduce body weight, control blood sugar in patients with type 2 diabetes, and manage weight-related complications such as moderate to severe obstructive sleep apnea
Human amylin has a strong tendency to aggregate into amyloid fibrils , similarly to amyloid in Alzheimers or -synuclein in Parkinsons
Everyone can benefit from it